The FDA approval of robotics for prostate cancer treatment in 2000 was based upon a trial conducted by the robotic company itself. Aside from this serious conflict of interest, the trial had two other major problems: a) the study was undertaken only on diseased gallbladders b) when the 113 men who had robotic surgery were […]

Outrage #1  That men continue to be deceived about and railroaded into unnecessary treatments for the so-called Gleason 6 (3+3) prostate “cancer” has NO hallmarks of a cancer when on both clinical and molecular biology grounds it behaves as noncancerous, has no spreading potential and is not a health-risk. Only some high-grade prostate cancers are […]

FDA and Biased Urology Panelists  Recently, the Food and Drug Administration (FDA) and its urology panel of prostate cancer experts did not approve the application for the non-invasive, high-intensity-focused-ultrasound (HIFU) technology as a treatment option for localized prostate cancer, despite the fact that this innovative treatment modality has been used successfully outside of the US […]